Antonio Antela-Lopez

Santiago De Compostela, GA, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort.

Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort.

Journal: HIV medicine

Published: August 20, 2025

Quality of Life and Treatment Satisfaction in People with HIV Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Pooled Analysis from Observational Cohort Studies.

Quality of Life and Treatment Satisfaction in People with HIV Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Pooled Analysis from Observational Cohort Studies.

Journal: Infectious diseases and therapy

Published: July 22, 2025

Is less truly more? - reassessing antiretroviral efficacy - a safety analysis for HIV patients switching from triple to double regimens with integrase inhibitors: A systematic review and meta-analysis.

Is less truly more? - reassessing antiretroviral efficacy - a safety analysis for HIV patients switching from triple to double regimens with integrase inhibitors: A systematic review and meta-analysis.

Journal: Medicine

Published: June 11, 2025

Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV: A Real-World Data from the Spanish BICSTaR Cohort.

Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV: A Real-World Data from the Spanish BICSTaR Cohort.

Journal: HIV/AIDS (Auckland, N.Z.)

Published: May 09, 2025

Cross-sectional analysis of a cohort of people over 65 years of age living with HIV.

Cross-sectional analysis of a cohort of people over 65 years of age living with HIV.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: October 15, 2023

Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.

Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.

Journal: Frontiers in cellular and infection microbiology

Published: March 18, 2023

Effects of frailty, geriatric syndromes, and comorbidity on mortality and quality of life in older adults with HIV.

Effects of frailty, geriatric syndromes, and comorbidity on mortality and quality of life in older adults with HIV.

Journal: BMC geriatrics

Published: October 09, 2022

Patient-Reported Outcomes (PROs) in HIV Infection: Points to Consider and Challenges.

Patient-Reported Outcomes (PROs) in HIV Infection: Points to Consider and Challenges.

Journal: Infectious diseases and therapy

Published: May 27, 2022

Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir.

Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir.

Journal: Drug design, development and therapy

Published: January 04, 2022

Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817).

Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817).

Journal: PloS one

Published: December 27, 2021

New horizons in the pharmaceutical care of HIV patients on long-term antiretroviral treatment.

New horizons in the pharmaceutical care of HIV patients on long-term antiretroviral treatment.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: November 22, 2021

Redefining therapeutic success in HIV patients: an expert view.

Redefining therapeutic success in HIV patients: an expert view.

Journal: The Journal of antimicrobial chemotherapy

Published: June 02, 2021

Showing 1-12 of 55

Last Updated: 09/26/2026